GB9122721D0 - Methods - Google Patents

Methods

Info

Publication number: GB9122721D0
Authority: GB; United Kingdom
Prior art keywords: methods
Prior art date: 1991-10-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB919122721A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-25

Filing date

1991-10-25

Publication date

1991-12-11

1991-10-25 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

1991-10-25 Priority to GB919122721A priority Critical patent/GB9122721D0/en

1991-12-11 Publication of GB9122721D0 publication Critical patent/GB9122721D0/en

1992-10-15 Priority to AU28750/92A priority patent/AU2875092A/en

1992-10-15 Priority to PCT/US1992/008786 priority patent/WO1993007871A1/en

1992-10-15 Priority to JP5507789A priority patent/JPH07500595A/en

1992-10-15 Priority to EP19920922182 priority patent/EP0609335A4/en

1992-10-15 Priority to US08/211,881 priority patent/US5455247A/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)

GB919122721A 1991-10-25 1991-10-25 Methods Pending GB9122721D0 (en)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
GB919122721A GB9122721D0 (en)	1991-10-25	1991-10-25	Methods
AU28750/92A AU2875092A (en)	1991-10-25	1992-10-15	Methods for the treatment of hyperlipidemia using azaspiranes
PCT/US1992/008786 WO1993007871A1 (en)	1991-10-25	1992-10-15	Methods for the treatment of hyperlipidemia using azaspiranes
JP5507789A JPH07500595A (en)	1991-10-25	1992-10-15	Treatment method for hyperlipidemia using azaspirans
EP19920922182 EP0609335A4 (en)	1991-10-25	1992-10-15	Methods for the treatment of hyperlipidemia using azaspiranes.
US08/211,881 US5455247A (en)	1991-10-25	1992-10-15	Methods for the treatment of hyperlipidemia using azaspiranes

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919122721A GB9122721D0 (en)	1991-10-25	1991-10-25	Methods

Publications (1)

Publication Number	Publication Date
GB9122721D0 true GB9122721D0 (en)	1991-12-11

Family

ID=10703551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB919122721A Pending GB9122721D0 (en)	1991-10-25	1991-10-25	Methods

Country Status (5)

Country	Link
EP (1)	EP0609335A4 (en)
JP (1)	JPH07500595A (en)
AU (1)	AU2875092A (en)
GB (1)	GB9122721D0 (en)
WO (1)	WO1993007871A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT100566B (en) *	1991-06-07	1999-06-30	Smithkline Beecham Corp	IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE
GB9308780D0 (en) *	1993-04-28	1993-06-09	Smithkline Beecham Corp	Methods
US5708019A (en) *	1993-04-28	1998-01-13	Smithkline Beecham Corporation	Methods of treating hyperlipidemia using azaspirane derivatives
CA2571710A1 (en)	2004-06-24	2006-11-02	Nicholas Valiante	Small molecule immunopotentiators and assays for their detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4291030A (en) *	1980-07-25	1981-09-22	Unimed, Inc.	Method of lowering blood cholesterol
DE3522578A1 (en) *	1984-06-26	1986-01-02	Ciba-Geigy Ag, Basel	Spiro compound and process for its preparation
US4963557A (en) *	1987-09-28	1990-10-16	Smithkline Beecham Corporation	Immunomodulatory azaspiranes
PT100566B (en) *	1991-06-07	1999-06-30	Smithkline Beecham Corp	IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE

1991
- 1991-10-25 GB GB919122721A patent/GB9122721D0/en active Pending
1992
- 1992-10-15 EP EP19920922182 patent/EP0609335A4/en not_active Withdrawn
- 1992-10-15 WO PCT/US1992/008786 patent/WO1993007871A1/en not_active Ceased
- 1992-10-15 JP JP5507789A patent/JPH07500595A/en active Pending
- 1992-10-15 AU AU28750/92A patent/AU2875092A/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0609335A4 (en)	1994-10-12
AU2875092A (en)	1993-05-21
WO1993007871A1 (en)	1993-04-29
EP0609335A1 (en)	1994-08-10
JPH07500595A (en)	1995-01-19

Publication	Publication Date	Title
HU9302044D0 (en)	1993-11-29	Trans-joining ribosimes
HU9302983D0 (en)	1994-01-28	Quinoline-derivatives
GB9212404D0 (en)	1992-07-22	Pin-header
DE69220944D1 (en)	1997-08-21	Thyroplastieimplantat
IL102878A0 (en)	1993-01-31	Cyanophenylpyrroles
GB9205589D0 (en)	1992-04-29	Lockfast
HUT59814A (en)	1992-07-28	Wheal-chair
DE69208351D1 (en)	1996-03-28	Halovinylderivate
DE69218451D1 (en)	1997-04-24	Schiffrumpfschwingungsdämpfer
GB9218869D0 (en)	1992-10-21	Playball
GB9122735D0 (en)	1991-12-11	Methods
ZA92793B (en)	1992-11-25	Dartboards
GB9122721D0 (en)	1991-12-11	Methods
IL99374A0 (en)	1992-08-18	Wall-bidet
GB9123122D0 (en)	1991-12-18	Earthbond
GB9124169D0 (en)	1992-01-08	Alldrive
EP0516484A3 (en)	1993-05-26	Msk-modulator
EP0509271A3 (en)	1992-11-25	Siloxi-polytetrahydrofuran
ZA929236B (en)	1994-05-27	Benzoquinoxalines
GB9108334D0 (en)	1991-06-05	Decor-mate
GB9118059D0 (en)	1991-10-09	Wallplates
GB9215575D0 (en)	1992-09-02	Lghts
GB9123507D0 (en)	1992-01-02	Ellipsograph
GB2262094B (en)	1995-07-05	Indolylbenzoxazines
AU213P (en)	1993-01-05	MOONBEAM Galtonia candicans